A mechanistic framework for a priori pharmacokinetic predictions of orally inhaled drugs.
The fate of orally inhaled drugs is determined by pulmonary pharmacokinetic processes such as particle deposition, pulmonary drug dissolution, and mucociliary clearance. Even though each single process has been systematically investigated, a quantitative understanding on the interaction of processes...
Main Authors: | Niklas Hartung, Jens Markus Borghardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-12-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1008466 |
Similar Items
-
Towards a Quantitative Mechanistic Understanding of Localized Pulmonary Tissue Retention—A Combined In Vivo/In Silico Approach Based on Four Model Drugs
by: Anneke Himstedt, et al.
Published: (2020-04-01) -
Mechanistic modeling of generic orally inhaled drug products: A workshop summary report
by: Ross L. Walenga, et al.
Published: (2023-05-01) -
Pharmacokinetic Studies for Proving Bioequivalence of Orally Inhaled Drug Products – Critical Issues and Concepts.
by: Karan eThakkar, et al.
Published: (2015-06-01) -
Precision Cardio-Oncology: Use of Mechanistic Pharmacokinetic and Pharmacodynamic Modeling to Predict Cardiotoxicities of Anti-Cancer Drugs
by: Hai-ni Wen, et al.
Published: (2022-01-01) -
How Contingent and How a Priori Are Contingent a Priori Truths?
Published: (2020-05-01)